Methasterone 10 - Livewell Pharmaceuticals

First described in 1959 by Syntex, methyldrostanolone remained uncommercialized in its original form. It found limited medicinal application through dimethazine, a compound of two methyldrostanolone molecules. In 2005, it returned under the name Superdrol, sold as a supplement despite lacking FDA approval. The product's powerful anabolic profile made it popular, but its unapproved status led to swift FDA intervention, and by early 2006, it was withdrawn from the market amid rising regulatory concern.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Methasterone 10 by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.